Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Terminated 2Unknown 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 6Thoracic 3Gastrointestinal 3Sarcoma 2Breast 2Tumor-Agnostic 1Plasma cell 1

Conditions

Small Cell Lung Carcinoma 2Lung Neoplasms 1

Interventions

Carboplatin 1174Cisplatin 891Pemetrexed 847pembrolizumab 626Paclitaxel 609Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 264Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Chloroquine × Thoracic × Clear all
NCT05647330 2022-12-12

Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer

Henan Cancer Hospital

Phase 2 Unknown
55 enrolled
Thoracic

Lung Neoplasms

NCT00969306 2019-02-15

Chloroquine IV

Maastricht Radiation Oncology

Phase 1 Terminated
5 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT01575782 2017-07-18

Chloroquine

Maastricht Radiation Oncology

Phase 1 Terminated
5 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡